In this issue:
Cetuximab plus chemotherapy in resectable colorectal liver metastasis
TAS-102 +/- bevacizumab in chemorefractory metastatic colorectal cancer
Impact of disease progression on quality of life
Maintenance strategies in metastatic colorectal cancer
Capecitabine + temozolomide in RAS-mutated, MGMT-methylated colorectal cancer
Detection of recurrent colorectal cancer using circulating biomarkers
Communicating with older patients
End-of-life transitions in nursing home residents
Leisure-time physical activity and cancer risk
FOLFIRINOX as salvage treatment in advanced biliary tract cancer
Please login below to download this issue (PDF)